Revelation Biosciences, Inc. Warrant (REVBW) EPS by Year
REVBW
Revelation Biosciences, Inc. Warrant lost $23.95 per diluted share in fiscal year 2025. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Revelation Biosciences, Inc. Warrant has filed alongside them.
FY2025 annual
EPS (Diluted)-$23.95
Source SEC Filings (10-K/10-Q)Latest period Q2 FY2026, ended Jun 30, 2026ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
REVBW EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
More Revelation Biosciences, Inc. Warrant financials
What was Revelation Biosciences, Inc. Warrant's diluted earnings per share in fiscal year 2025?
Revelation Biosciences, Inc. Warrant lost $23.95 per diluted share in fiscal year 2025.
What was Revelation Biosciences, Inc. Warrant's diluted earnings per share in the most recent quarter?
Revelation Biosciences, Inc. Warrant (REVBW) reported -$0.87 in diluted earnings per share in Q2 2026.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Revelation Biosciences, Inc. Warrant (REVBW) reported on that line in every period on record.
